[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-363484-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-363484-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","map30-a-type-i-ribosome-inactivating-protein-inhibits-hepatocellular-carcinoma-by-inducing-apoptosis-through-mitochondria","MAP30, a type Ⅰ ribosome-inactivating protein, inhibits hepatocellular carcinoma by inducing apoptosis through mitochondria","","MAP30, a 30 kDa type I ribosome-inactivating protein purified from Momordica charantia L., was investigated for its anti-liver-cancer potential. Although prior work suggested antiproliferative and multitarget biological activities, its effects and underlying mechanism in hepatocellular carcinoma remained unclear. Using SK-Hep-1 cell assays, MAP30 inhibited proliferation, caused G1 arrest, and triggered apoptosis via mitochondrial signaling involving increased ROS and reduced mitochondrial membrane potential.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/map30-a-type-i-ribosome-inactivating-protein-inhibits-hepatocellular-carcinoma-by-inducing-apoptosis-through-mitochondria/363484/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/map30-a-type-i-ribosome-inactivating-protein-inhibits-hepatocellular-carcinoma-by-inducing-apoptosis-through-mitochondria/363484.png","ImageObject",300,407,{"name":42,"@type":43},"McGucket","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-01","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is MAP30 and what biological activity was investigated?","Question",{"text":63,"@type":64},"MAP30 is a 30 kDa type I ribosome-inactivating protein from Momordica charantia L. The study evaluates its ability to inhibit hepatocellular carcinoma by inducing apoptosis.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was apoptosis and cell cycle impact measured in SK-Hep-1 cells?",{"text":68,"@type":64},"Cell proliferation was assessed using a CCK-8 assay. Apoptosis, cell cycle, ROS levels, and mitochondrial membrane potential were measured by flow cytometry, with apoptosis-related proteins analyzed by Western blot.",{"name":70,"@type":61,"acceptedAnswer":71},"What mechanism links MAP30-induced apoptosis to mitochondria?",{"text":72,"@type":64},"MAP30-induced apoptosis is associated with mitochondrial pathway activation, evidenced by increased reactive oxygen species and decreased mitochondrial membrane potential, along with synchronized changes in caspase-3, caspase-9, PARP, and BCL-2.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},363484,1790471310,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":116,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1236954412713,"https://us-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","®  \n Clinical Trial/Experimental Study   \nMAP30, a type Ⅰ ribosome-inactivating protein, inhibits hepatocellular carcinoma by inducing apoptosis through mitochondria  \nDi Yang, MSa , Di Peng, MSb , Di Jia, MSb , Yiping Zhou, MSc , Houke Li, MSb , Zongxing Jiang, MDd , Yao Meng, PhDb ,*  \n\n| Abstract\u003Cbr>Background: We have purified Momordica anti-HIV protein of 30 kDa (MAP30), a type I ribosome-inactivating protein from Momordica charantia L. with approximately 30 kDa, which inhibited protein synthesis through N-glycosylase activity and exhibited antiviral, antibacterial, antitumor and other biological activities. It is speculated that MAP30 may be a potential natural active agent for prevention and treatment of liver cancer. However, its effect on liver cancer and underlying mechanism are still unclear now. Therefore, the purpose of this manuscript was to explore the molecular mechanism of MAP30 on liver cancer.\u003Cbr>Methods: The cell counting kit-8 assay was used to detect the proliferation of SK-Hep-1 cells. The apoptosis, cell cycle, reactive oxygen species level and mitochondrial membrane potential of SK-Hep-1 cells were detected by flow cytometry. Protein levels were determined by Western blot.\u003Cbr>Results: It was confirmed that MAP30 can significantly inhibit the proliferation of SK-Hep-1 cells, arrest the cell cycle in G1 phase and induce apoptosis. Further studies on apoptosis-related proteins showed that the expression of caspase-3, caspase-9, poly (ADP-ribose) polymerase and B-cell lymphoma 2 proteins decreased synchronously in a time-and dose-dependent manner. In addition, MAP30-induced apoptosis of SK-Hep-1 cells was found to be closely related to the mitochondrial pathway through the increase of reactive oxygen species and the decrease of mitochondrial membrane potential.\u003Cbr>Conclusion: The manuscript indicated that MAP30 may be a potential antitumor drug which provided an experimental basis for further exploration of the mechanism of MAP30 prevention and treatment of liver cancer, and was expected to be applied in medicine and biotechnology.\u003Cbr>Abbreviations: bcl-2 = B-cell lymphoma 2, CCK-8 = cell counting kit-8, DMEM = Dulbecco modified eagle’s medium, DNA = deoxyribonucleic acid, MAP30 = Momordica anti-HIV protein of 30 kDa, JC-1 = 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolylcarbocyanine iodide, MMP = mitochondrial membrane potential, PARP = poly (ADP-ribose) polymerase, RIPs = ribosome-inactivating proteins, ROS = reactive oxygen species, SDS-PAGE = sodium dodecyl sulfate polyacrylamide gel electrophoresis, V-FITC/PI = V-fluorescein isothiocyanate/propidium iodide. |\n| --- |\n| Keywords: apoptosis, hepatocellular carcinoma, mitochondria, Momordica anti-HIV protein of 30 kDa (MAP30) , ribosomeinactivating proteins (RIPs), SK-Hep-1 |\n\nDY, DP, and DJ contributed to this article equally.  \nThis research was funded by Natural Science Foundation of China, grant number 31600269; Science and Technology Program of Sichuan Province, grant number 2025ZNSFSC0551; Collaborative Fund of Chengdu Medical College–People’s Hospital of Pidu District in Chengdu, grant number 24LHFYSZ1-32; Key Project of Chengdu Medical College Research Program, CYZZD24-10; Collaborative Fund of Chengdu Medical College–Nanbu People’s Hospital, grant number 23LHNBZYB18; The Innovation Project of Chengdu Medical College, grant number YCX2025-01-137, YCX2024-01-99; Special project of Liyan Workshop Medical Aesthetics Research Center of Chengdu Medical College, grant number 23YM04.  \nThe authors have no conflicts of interest to disclose.  \nAll data generated or analyzed during this study are included in this published article [and its supplementary information files].  \nThis study was approved by the Biomedical Ethics Committee of the University in accordance with the ethical guidelines of the National Food and Drug Administration and the National Health Commission (2020), the World Medical Association Helsinki Declaration (2013) and the Coun","cbCairIF4pCFiVtY","https://ap.wps.com/l/cbCairIF4pCFiVtY","pdf",2097764,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Keywords","[{\"question\":\"What is MAP30 and what biological activity was investigated?\",\"answer\":\"MAP30 is a 30 kDa type I ribosome-inactivating protein from Momordica charantia L. The study evaluates its ability to inhibit hepatocellular carcinoma by inducing apoptosis.\"},{\"question\":\"How was apoptosis and cell cycle impact measured in SK-Hep-1 cells?\",\"answer\":\"Cell proliferation was assessed using a CCK-8 assay. Apoptosis, cell cycle, ROS levels, and mitochondrial membrane potential were measured by flow cytometry, with apoptosis-related proteins analyzed by Western blot.\"},{\"question\":\"What mechanism links MAP30-induced apoptosis to mitochondria?\",\"answer\":\"MAP30-induced apoptosis is associated with mitochondrial pathway activation, evidenced by increased reactive oxygen species and decreased mitochondrial membrane potential, along with synchronized changes in caspase-3, caspase-9, PARP, and BCL-2.\"}]","MAP30, a type Ⅰ ribosome-inactivating protein, inhibits hepatocellular carcinoma by inducing apoptosis through mitochondria | PDF",1790151442,23,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3b6371163ec420eb03fad9a435b3e7c4.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/401dbc16c486a36b277c41117f68fa42.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d6874a20f6ce593bb4a98bf69f8d2874.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/780b5ffac1a203ba03d693510b3242f1.webp",980,1306]